PT65719B - PROCESS FOR THE PREPARATION OF NEW GALENIC PREPARATIONS - Google Patents

PROCESS FOR THE PREPARATION OF NEW GALENIC PREPARATIONS

Info

Publication number
PT65719B
PT65719B PT65719A PT6571976A PT65719B PT 65719 B PT65719 B PT 65719B PT 65719 A PT65719 A PT 65719A PT 6571976 A PT6571976 A PT 6571976A PT 65719 B PT65719 B PT 65719B
Authority
PT
Portugal
Prior art keywords
preparation
galenic preparations
new galenic
new
preparations
Prior art date
Application number
PT65719A
Other languages
French (fr)
Portuguese (pt)
Other versions
PT65719A (en
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT65719A publication Critical patent/PT65719A/en
Publication of PT65719B publication Critical patent/PT65719B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
PT65719A 1975-10-17 1976-10-15 PROCESS FOR THE PREPARATION OF NEW GALENIC PREPARATIONS PT65719B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (en) 1975-10-17 1975-10-17 Solid substances made from polyvinylpyrrolidone and ergot alkaloids

Publications (2)

Publication Number Publication Date
PT65719A PT65719A (en) 1976-11-01
PT65719B true PT65719B (en) 1978-06-12

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65719A PT65719B (en) 1975-10-17 1976-10-15 PROCESS FOR THE PREPARATION OF NEW GALENIC PREPARATIONS

Country Status (28)

Country Link
JP (1) JPS5854122B2 (en)
AT (1) AT362510B (en)
AU (1) AU508628B2 (en)
BE (1) BE847368A (en)
CA (1) CA1079641A (en)
CH (1) CH643737A5 (en)
CS (1) CS199647B2 (en)
DE (1) DE2546577B2 (en)
DK (1) DK146194C (en)
ES (1) ES452420A1 (en)
FI (1) FI762875A (en)
FR (1) FR2327764A1 (en)
GB (1) GB1560406A (en)
GR (1) GR61268B (en)
HK (1) HK3183A (en)
HU (1) HU172533B (en)
IE (1) IE43778B1 (en)
IL (1) IL50686A (en)
MY (1) MY8400063A (en)
NL (1) NL184558C (en)
NO (1) NO144468C (en)
NZ (1) NZ182341A (en)
PH (1) PH14513A (en)
PT (1) PT65719B (en)
SE (1) SE430379B (en)
SG (1) SG63082G (en)
SU (1) SU1165223A3 (en)
ZA (1) ZA766166B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
FR2454804B1 (en) * 1979-04-26 1986-11-21 Sanofi Sa DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
ATE72111T1 (en) * 1987-01-14 1992-02-15 Ciba Geigy Ag THERAPEUTIC SYSTEM FOR POORLY SOLUBLE ACTIVE INGREDIENTS.
FR2610827B1 (en) * 1987-02-18 1991-09-13 Pf Medicament DIHYDROERGOTAMINE (D.H.E.) TABLET OF THE HYDROPHILIC MATRIX TYPE AND MANUFACTURING METHOD THEREOF
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (en) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimally releasing kava extracts
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
NZ504834A (en) * 1997-12-22 2001-12-21 Schering Corp Tricyclic amide molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
WO2001039742A2 (en) * 1999-12-03 2001-06-07 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
AU2003304242A1 (en) * 2003-06-27 2005-01-13 Bioprogress S.P.A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
NZ182341A (en) 1978-09-20
IE43778L (en) 1977-04-17
JPS5251014A (en) 1977-04-23
NO144468C (en) 1981-09-09
ZA766166B (en) 1978-05-30
FR2327764B1 (en) 1979-03-02
DK146194B (en) 1983-07-25
NL7611295A (en) 1977-04-19
DK454176A (en) 1977-04-18
FR2327764A1 (en) 1977-05-13
SU1165223A3 (en) 1985-06-30
BE847368A (en) 1977-04-15
IE43778B1 (en) 1981-05-20
HK3183A (en) 1983-01-20
SE430379B (en) 1983-11-14
ATA767976A (en) 1980-10-15
GR61268B (en) 1978-10-17
NO763446L (en) 1977-04-19
GB1560406A (en) 1980-02-06
DK146194C (en) 1984-01-02
CS199647B2 (en) 1980-07-31
SG63082G (en) 1983-09-09
NL184558C (en) 1989-09-01
SE7611189L (en) 1977-04-18
PT65719A (en) 1976-11-01
IL50686A (en) 1979-05-31
NL184558B (en) 1989-04-03
FI762875A (en) 1977-04-18
PH14513A (en) 1981-08-24
AU1875476A (en) 1978-04-20
AT362510B (en) 1981-05-25
JPS5854122B2 (en) 1983-12-02
NO144468B (en) 1981-06-01
IL50686A0 (en) 1976-12-31
HU172533B (en) 1978-09-28
MY8400063A (en) 1984-12-31
CH643737A5 (en) 1984-06-29
CA1079641A (en) 1980-06-17
DE2546577A1 (en) 1977-04-21
AU508628B2 (en) 1980-03-27
DE2546577B2 (en) 1981-04-02
ES452420A1 (en) 1978-04-16

Similar Documents

Publication Publication Date Title
BE846555A (en) PROCESS FOR THE PREPARATION OF POLYURETHANNES
RO74936A (en) PROCESS FOR THE PREPARATION OF MERCAPTOAZETIDIONES
PT65719A (en) PROCESS FOR THE PREPARATION OF NEW GALENIC PREPARATIONS
BE838754A (en) IMPROVED PROCESS FOR THE PREPARATION OF DIMETHYLOL-2, 2-ALCANALS
PT65388A (en) PROCESS FOR THE PREPARATION OF PEPTIDES
RO69608A (en) PROCESS FOR THE PREPARATION OF 1,2-BENZISOTHIAZOLE-3-ONES
FR2307827A1 (en) PROCESS FOR THE PREPARATION OF HEXAFLUOROPROPENE OLIGOMERS
FR2303541A1 (en) PROCESS FOR THE PREPARATION OF NEW INDOLYLALCOYLPIPERIDINES
BE838823A (en) PROCESS FOR THE PREPARATION OF 1,2,5-DIHYDROXYCHOLECALCIFEROL
RO72547A (en) PROCESS FOR THE PREPARATION OF 2 ', 3,6'-TRICHLORE-4-CYAN-4'-BENZOYLUREIDODPHENYL ESTERS
FR2335522A1 (en) PROCESS FOR THE PREPARATION OF ANDROSTENE-4 DIONES-3,17
BE842584A (en) PROCESS FOR THE PREPARATION OF GEMINATED DIHALOGENIDES
RO70079A (en) PROCESS FOR THE PREPARATION OF N-ARYL-N- (4-PYPERIDINYL) -LARYLACETAMIDES
FR2314192A1 (en) PROCESS FOR PREPARATION OF OXAPHOSPHOLANES-1,2
PT64718B (en) PROCESS FOR THE PREPARATION OF PHENYALCOYLAMINES
RO76667A (en) PROCESS FOR THE PREPARATION OF 2,4-DIALKYAMINO-6-CHLORINE-5-TRIAZINES
BE845327A (en) PROCESS FOR THE PREPARATION OF 4,4'-DIHYDROXY-3-3'-5-5'-TRETRALCOYLDIPHENYLALCANES
RO72558A (en) PROCESS FOR THE PREPARATION OF CYCLOALCANPYRAZOLES
RO70232A (en) PROCESS FOR THE PREPARATION OF 4-PYRAZOLIL-4H-1,2,4-TRIAZOLILE
PT64691B (en) PROCESS FOR THE PREPARATION OF 6,11-DI-HYDRO-11-OXO-DIBENZ / B, E / OXEPIN-ALKANOIC ACIDS
FR2317290A1 (en) PROCESS FOR THE PREPARATION OF 5-CYANOPYRIDONES- (6)
FR2348174A1 (en) PROCESS FOR THE PREPARATION OF GEMINATED DIHALOGENIDES
FR2296628A1 (en) PROCESS FOR THE PREPARATION OF CHLOROAMINO-S-TRIAZINES
FR2331565A1 (en) PROCESS FOR THE PREPARATION OF TRIARYLBORANE
FR2313336A2 (en) PROCESS FOR THE PREPARATION OF CYCLOALCANONES AND CYCLOALCANOLS